Kyverna Therapeutics Growth Metrics (2023-2026) | KYTX

Growth Metrics Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Assets Growth (1y) (Quarter) 305.14%-33.16%-37.62%-44.82%-3.55%-1.39%
Assets (QoQ) (Quarter) 418.63%-6.89%-6.59%-10.19%-14.44%-13.10%-17.37%57.00%-12.53%
Capital Expenditures Growth (1y) (Quarter) 1,839.29%-10,760.00%533.71%59.28%100.74%-100.24%-99.06%
Capital Expenditures (QoQ) (Quarter) -117.86%5,380.00%26.52%62.57%-200.00%408.10%-68.20%-200.00%225.00%
Cash & Equivalents Growth (1y) (Quarter) 463.73%146.34%355.71%178.87%-74.65%-60.42%-67.36%28.43%-49.53%
Cash & Equivalents Growth (3y) (Quarter) -10.32%
Cash & Equivalents (QoQ) (Quarter) 34.29%-57.01%50.86%547.35%-41.32%-20.48%-7.68%-41.15%-8.38%-34.43%263.23%-76.87%
Cash from Investing Activities Growth (1y) (Quarter) -999.88%-2,263,933.33%101.25%-7.76%104.54%142.94%3,236.83%-159.16%-999.98%
Cash from Investing Activities Growth (3y) (Quarter) -78.38%
Cash from Investing Activities (QoQ) (Quarter) -100.02%-1,803,833.33%158.54%-487.86%44.73%101.00%4,222.78%-80.91%422.89%-22.66%-176.64%-190.40%
Cash from Operations Growth (1y) (Quarter) -122.77%-114.76%-146.94%-100.03%-75.91%-32.22%-57.59%9.69%7.35%
Cash from Operations Growth (3y) (Quarter) -53.70%
Cash from Operations (QoQ) (Quarter) 1.75%1.11%-66.66%-37.58%5.29%-13.71%-35.00%-20.99%28.81%-35.53%22.64%-24.12%
EBIT Growth (1y) (Quarter) -156.51%-151.35%-138.12%-91.99%-61.48%-32.82%0.11%4.29%12.74%
EBIT Growth (3y) (Quarter) -53.47%
EBIT (QoQ) (Quarter) -16.23%-22.40%-31.29%-37.33%-13.89%-15.96%-5.86%-15.51%6.32%12.80%-1.43%-5.31%
EBT Growth (1y) (Quarter) -139.38%-119.96%-122.93%-81.70%-67.28%-46.14%-6.64%-0.87%10.99%
EBT Growth (3y) (Quarter) -52.75%
EBT (QoQ) (Quarter) -17.45%-18.10%-33.54%-29.23%-7.92%-19.69%-8.84%-18.98%5.71%12.66%-2.96%-4.99%
Enterprise Value Growth (1y) (Quarter) -829.46%-548.02%-1,300.21%-396.98%34.38%39.25%46.78%2.35%4.00%
Enterprise Value Growth (3y) (Quarter) -80.24%
Enterprise Value (QoQ) (Quarter) -34.29%57.01%-150.55%-542.64%6.37%7.12%11.07%15.15%13.32%18.62%-63.15%16.58%
EPS (Basic) Growth (1y) (Quarter) 90.74%96.79%96.56%96.72%8.04%-44.78%-6.25%10.23%35.92%
EPS (Basic) Growth (3y) (Quarter) 62.08%
EPS (Basic) (QoQ) (Quarter) -72.40%-11.55%-15.43%95.83%40.18%-19.40%-10.00%-17.05%5.83%12.37%7.06%16.46%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) 90.74%96.79%96.56%96.72%8.04%-44.78%-6.25%10.23%35.92%
EPS (Weighted Average and Diluted) Growth (3y) (Quarter) 62.08%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) -72.40%-11.55%-15.43%95.83%40.18%-19.40%-10.00%-17.05%5.83%12.37%7.06%16.46%
Free Cash Flow Growth (1y) (Quarter) -126.95%-110.02%-155.90%-99.31%-72.24%-35.27%-48.54%10.95%7.35%
Free Cash Flow Growth (3y) (Quarter) -53.57%
Free Cash Flow (QoQ) (Quarter) 2.04%-1.28%-65.73%-38.02%9.34%-23.40%-29.08%-19.28%28.80%-35.50%22.62%-24.11%
Interest Coverage Ratio Growth (1y) (Quarter) -156.51%-196.47%-272.06%-234.20%-184.21%-270.01%-356.64%94.18%96.73%
Interest Coverage Ratio Growth (3y) (Quarter) 37.99%
Interest Coverage Ratio (QoQ) (Quarter) -11.17%-12.61%-39.67%-46.70%-28.49%-41.32%-25.46%-24.75%-67.28%-74.41%98.40%29.90%
Net Cash Flow Growth (1y) (Quarter) 9,137.46%-779.06%11.47%-169.30%-120.95%96.28%28.51%1,209.83%-131.28%
Net Cash Flow Growth (3y) (Quarter) -260.28%
Net Cash Flow (QoQ) (Quarter) 564.69%-323.22%138.39%1,521.73%-148.86%70.90%69.95%-390.33%91.33%-459.37%566.60%-202.18%
Net Income Growth (1y) (Quarter) -139.38%-119.96%-122.93%-81.70%-67.28%-46.14%-6.64%-0.87%10.99%
Net Income Growth (3y) (Quarter) -52.75%
Net Income (QoQ) (Quarter) -17.45%-18.10%-33.54%-29.23%-7.92%-19.69%-8.84%-18.98%5.71%12.66%-2.96%-4.99%
Net Income towards Common Stockholders Growth (1y) (Quarter) -139.38%-119.96%-122.93%-81.70%-67.28%-46.14%-6.64%-0.87%10.99%
Net Income towards Common Stockholders Growth (3y) (Quarter) -52.75%
Net Income towards Common Stockholders (QoQ) (Quarter) -17.45%-18.10%-33.54%-29.23%-7.92%-19.69%-8.84%-18.98%5.71%12.66%-2.96%-4.99%
Operating Income Growth (1y) (Quarter) -156.51%-151.35%-138.12%-91.99%-61.48%-32.82%0.11%4.29%12.74%
Operating Income Growth (3y) (Quarter) -53.47%
Operating Income (QoQ) (Quarter) -16.23%-22.40%-31.29%-37.33%-13.89%-15.96%-5.86%-15.51%6.32%12.80%-1.43%-5.31%
Profit After Tax Growth (1y) (Quarter) -139.55%-120.02%-123.03%-81.11%-67.09%-46.10%-6.65%-0.83%10.99%
Profit After Tax Growth (3y) (Quarter) -52.73%
Profit After Tax (QoQ) (Quarter) -17.48%-18.13%-33.85%-28.95%-7.90%-19.75%-8.69%-18.97%5.65%12.58%-2.75%-5.03%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) 43.90%-10.24%-35.77%-43.10%-53.81%-44.87%
Property, Plant & Equipment (Net) (QoQ) (Quarter) 16.68%24.02%-6.39%6.22%-27.22%-11.25%-17.07%-13.78%-13.13%
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -2631.00-5577.00-6081.00-3376.00-222.00
Return on Capital Employed (QoQ) (Quarter) 966.00-995.00-1109.00-1494.00-1979.00-1499.001,596.001,660.00
Return on Equity Growth (1y) (Quarter) -1.000.00-1.00-1.000.000.00
Return on Equity (QoQ) (Quarter) -1.000.000.000.000.000.000.000.000.00
Share-based Compensation Growth (1y) (Quarter) 386.75%187.89%555.09%76.28%-5.14%96.11%-20.92%95.51%46.74%
Share-based Compensation Growth (3y) (Quarter) 89.23%
Share-based Compensation (QoQ) (Quarter) -4.70%16.82%50.48%190.56%-43.63%165.81%-59.51%56.37%16.52%7.19%0.11%17.36%
Shareholder's Equity Growth (1y) (Quarter) 526.64%443.13%370.75%2,128.97%-37.95%-44.72%-49.80%-12.87%-12.69%
Shareholder's Equity Growth (3y) (Quarter) 62.76%
Shareholder's Equity (QoQ) (Quarter) -14.87%-15.03%88.25%2,847.48%-7.61%-9.23%-11.93%-15.97%-17.69%-17.59%52.87%-15.80%
Total Debt (QoQ) (Quarter) 0.28%